News 23 Apr 2024 BGG from China opens headquarters in Basel BGG is establishing new global headquarters in Basel, from which it plans to grow in Europe and the USA. The Beijing-based company is a supplier ...
Aktuell 23 Apr 2024 BGG aus China eröffnet Hauptsitz in Basel BGG richtet in Basel einen neuen globalen Hauptsitz ein und will von dort aus in Europa und den USA expandieren. Das Pekinger Unternehmen ist ein...
最新 25 Dic 2023 瑞士初创公司 Zynnon在呼吸道感染的诊断方面实现突破 Zynnon在诊断病毒性呼吸道感染的技术上实现突破。在医院成功研究后,这家来自大苏黎世地区的公司已开始生产原型。随后还将进行进一步的临床试验。
News 29 Gen 2024 Biomanufacturing innovator Stämm opens its European R&D facility in Monthey Stämm, an innovative leader in bioprocessing technology, has announced the opening of its new R&D facility at the BioArk in Monthey, in the canto...
Actualités 29 Gen 2024 L’innovateur en bioproduction Stämm ouvre son centre européen de R&D à Monthey Stämm, une entreprise leader en matière d’innovation dans les technologies de bioprocédés, a annoncé l’ouverture de son nouveau centre de R&D au ...
News 22 Dic 2023 Zynnon hits milestone in the diagnosis of respiratory infections Zynnon has reached a milestone with its technology for diagnosing viral respiratory infections. Following successful studies in hospitals, the co...
News 19 Dic 2023 Top Stories from Western Switzerland (October-December 2023) From achieving top rankings in global innovation to making significant advancements in healthcare and technology, discover Western Switzerland's ...
Événements S-GE Facteurs de succès clés pour faire des affaires au Japon 23 Apr 2024 10:15–12:10 Zürich Svizzera
Aktuell 26 Mar 2024 Zürcher Forschende machen Krebstherapie wieder wirksam Forschende der Universität Zürich und des Universitätsspitals Zürich haben herausgefunden, wie mutierte Blutkrebszellen wieder auf eine Immunther...
Evento S-GE Fattori chiave di successo per fare affari in Giappone 23 Apr 2024 10:15–12:10 Zürich Svizzera
Actualités 19 Dic 2023 Les Grands Titres de Suisse occidentale (Octobre-Décembre 2023) De l’obtention des meilleurs classements en matière d’innovation mondiale à la réalisation d’avancées significatives dans les domaines de la sant...
News 04 Dic 2023 Siegfried, a Swiss leader taking innovations to industrial scale for the pharmaceutical industry From a small operation in Aargau to a global CDMO powerhouse, Siegfried's journey reflects strategic growth, innovation, and a deep commitment to...
News 10 Nov 2021 Geistlich Pharma’s collagen membrane authorized for use in the USA The Geistlich Nexo-Gide has obtained clearance from the US Food and Drug Administration (FDA). The collagen membrane developed by Geistlich Pharm...
News 19 Ott 2023 Researchers reverse prostate cancer therapy resistance Researchers at the Institute of Oncology Research (IOR) have discovered how to reverse prostate cancer therapy resistance. This advancement came ...
News 10 Nov 2023 Researchers heal wounds with lactobacilli Researchers from Switzerland and the USA have jointly developed a dressing that uses probiotics to eliminate pathogens in chronic wounds. The pro...
Actualités 04 Dic 2023 Siegfried, un leader suisse qui porte les innovations pharmaceutiques à l’échelle industrielle D’une petite opération en Argovie à un géant mondial du CDMO, le parcours de Siegfried repose sur une croissance stratégique, l’innovation et un ...
News 07 Ago 2023 Longevity start-up EPITERNA raises EUR 10 million to slow ageing and extend lifespan Vaud-based longevity start-up EPITERNA has secured EUR 10 million in funding from Prima Materia, an investment firm founded by Spotify founder Da...
Aktuell 10 Nov 2021 Kollagenmembran von Geistlich Pharma erhält Zulassung in den USA Geistlich Nexo-Gide hat die Zulassung der amerikanischen Aufsichtsbehörde erhalten. Die von Geistlich Pharma entwickelte Kollagenmembran unterstü...